Dr. Claudia Krieger-Grübel
Gastroenterology/Hepatology · Dept. I
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.
Woelfel S, Junker D, Bergamin I, Meyer-Herbon P, Stillhard R, Graf N, Leinenkugel G, Dütschler J, König M, Häuptle R, Zwyssig S, Krieger-Grübel C, Truniger S, Koller S, Metzger-Peter K, Frei N, Genetics And Observational Subarachnoid Haemorrhage Gosh Study Investigators, Albrich W, Friedrich M, Bernsmeier C, Niess J, Korte W, Bürgi J, Dulovic A, Schneiderhan-Marra N, Semela D, Brand S. STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease. Vaccines (Basel) 2024; 12
Oct 31, 2024STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.
Oct 31, 2024Vaccines (Basel) 2024; 12
Woelfel Simon, Junker Daniel, Bergamin Irina, Meyer-Herbon Pamela, Stillhard Roman, Graf Nicole, Leinenkugel Georg, Dütschler Joel, König Marius, Häuptle Rahel, Zwyssig Sarah, Krieger-Grübel Claudia, Truniger Samuel, Koller Seraina, Metzger-Peter Katline, Frei Nicola Fabian, Genetics And Observational Subarachnoid Haemorrhage Gosh Study Investigators, Albrich Werner, Friedrich Matthias, Bernsmeier Christine, Niess Jan-Hendrik, Korte Wolfgang C, Bürgi Justus J, Dulovic Alex, Schneiderhan-Marra Nicole, Semela David, Brand Stephan
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.
Woelfel S, Dütschler J, Junker D, König M, Graf N, Krieger-Grübel C, Truniger S, Oikonomou V, Leinenkugel G, Koller S, Metzger-Peter K, Wyss J, Krupka N, Frei N, STAR SIGN Study Investigators, Albrich W, Friedrich M, Niess J, Schneiderhan-Marra N, Dulovic A, Misselwitz B, Korte W, Bürgi J, Brand S. XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease. Aliment Pharmacol Ther 2024
Oct 29, 2024XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.
Oct 29, 2024Aliment Pharmacol Ther 2024
Woelfel Simon, Dütschler Joel, Junker Daniel, König Marius, Graf Nicole, Krieger-Grübel Claudia, Truniger Samuel, Oikonomou Vasileios, Leinenkugel Georg, Koller Seraina, Metzger-Peter Katline, Wyss Jacqueline, Krupka Niklas, Frei Nicola Fabian, STAR SIGN Study Investigators, Albrich Werner, Friedrich Matthias, Niess Jan-Hendrik, Schneiderhan-Marra Nicole, Dulovic Alex, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
Woelfel S, Dütschler J, Junker D, König M, Leinenkugel G, Graf N, Krieger-Grübel C, Truniger S, Franke A, Koller S, Metzger-Peter K, Oberholzer M, Frei N, Geissler N, Schaub P, Genetics And Observational Subarachnoid Haemorrhage Gosh Study Investigators, Albrich W, Friedrich M, Niess J, Schneiderhan-Marra N, Dulovic A, Korte W, Bürgi J, Brand S. Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease. Vaccines (Basel) 2024; 12
Jul 15, 2024Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
Jul 15, 2024Vaccines (Basel) 2024; 12
Woelfel Simon, Dütschler Joel, Junker Daniel, König Marius, Leinenkugel Georg, Graf Nicole, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Koller Seraina, Metzger-Peter Katline, Oberholzer Melanie, Frei Nicola Fabian, Geissler Nora, Schaub Peter, Genetics And Observational Subarachnoid Haemorrhage Gosh Study Investigators, Albrich Werner, Friedrich Matthias, Niess Jan-Hendrik, Schneiderhan-Marra Nicole, Dulovic Alex, Korte Wolfgang C, Bürgi Justus J, Brand Stephan
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Woelfel S, Dütschler J, König M, Dulovic A, Graf N, Junker D, Oikonomou V, Krieger-Grübel C, Truniger S, Franke A, Eckhold A, Forsch K, Koller S, Wyss J, Krupka N, Oberholzer M, Frei N, Geissler N, Schaub P, STAR SIGN Study Investigators, Albrich W, Friedrich M, Schneiderhan-Marra N, Misselwitz B, Korte W, Bürgi J, Brand S. STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2023; 58:678-691.
Aug 12, 2023STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Aug 12, 2023Aliment Pharmacol Ther 2023; 58:678-691
Woelfel Simon, Dütschler Joel, König Marius, Dulovic Alex, Graf Nicole, Junker Daniel, Oikonomou Vasileios, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Eckhold Annika, Forsch Kristina, Koller Seraina, Wyss Jacqueline, Krupka Niklas, Oberholzer Melanie, Frei Nicola Fabian, Geissler Nora, Schaub Peter, STAR SIGN Study Investigators, Albrich Werner, Friedrich Matthias, Schneiderhan-Marra Nicole, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Woelfel S, Dütschler J, König M, Graf N, Oikonomou V, Krieger-Grübel C, Truniger S, Franke A, Eckhold A, Forsch K, Wyss J, Krupka N, Albrich W, Frei N, Geissler N, Schaub P, STAR SIGN Study Investigators, Friedrich M, Misselwitz B, Korte W, Bürgi J, Brand S. Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2. Aliment Pharmacol Ther 2022; 57:103-116.
Oct 28, 2022Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Oct 28, 2022Aliment Pharmacol Ther 2022; 57:103-116
Woelfel Simon, Dütschler Joel, König Marius, Graf Nicole, Oikonomou Vasileios, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Eckhold Annika, Forsch Kristina, Wyss Jacqueline, Krupka Niklas, Albrich Werner, Frei Nicola Fabian, Geissler Nora, Schaub Peter, STAR SIGN Study Investigators, Friedrich Matthias, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan
Attitudes and expectations of patients on home parenteral nutrition towards eHealth: A multicenter survey.
Schönenberger K, Reber E, Vu D, Krieger-Grübel C, Gerber P, Muri R, Huwiler V, Mühlebach S, Leuenberger M, Stanga Z. Attitudes and expectations of patients on home parenteral nutrition towards eHealth: A multicenter survey. Clin Nutr ESPEN 2022; 52:445-449.
Sep 29, 2022Attitudes and expectations of patients on home parenteral nutrition towards eHealth: A multicenter survey.
Sep 29, 2022Clin Nutr ESPEN 2022; 52:445-449
Schönenberger Katja A, Reber Emilie, Vu Duy-Tan, Krieger-Grübel Claudia, Gerber Philipp A, Muri Raphaela, Huwiler Valentina V, Mühlebach Stefan, Leuenberger Michèle, Stanga Zeno
Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study
Krieger-Grübel C, Hutter S, Hiestand M, Brenner I, Güsewell S, Borovicka J. Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study. Clin Nutr ESPEN 2020; 40:83-89.
Oct 6, 2020Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study
Oct 6, 2020Clin Nutr ESPEN 2020; 40:83-89
Krieger-Grübel Claudia, Hutter Senta, Hiestand Mirjam, Brenner Isabella, Güsewell Sabine, Borovicka Jan
Effect of morbid obesity, gastric banding and gastric bypass on esophageal symptoms, mucosa and function
Borovicka J, Meyenberger C, Fried M, Pohl D, Bisang P, Gutzwiler J, Sulz M, Schultes B, Thurnheer M, van der Weg B, Krieger-Grübel C, Tutuian R. Effect of morbid obesity, gastric banding and gastric bypass on esophageal symptoms, mucosa and function. Surg Endosc 2016
Jun 10, 2016Effect of morbid obesity, gastric banding and gastric bypass on esophageal symptoms, mucosa and function
Jun 10, 2016Surg Endosc 2016
Borovicka Jan, Meyenberger Christa, Fried Michael, Pohl Daniel, Bisang Philipp, Gutzwiler Jean-Pierre, Sulz Michael, Schultes Bernd, Thurnheer Martin, van der Weg Boudewijn, Krieger-Grübel Claudia, Tutuian Radu
Correlation of esophageal clearance and dysphagia symptom assessment after treatment for achalasia
Krieger-Grübel C, Tutuian R, Borovicka J. Correlation of esophageal clearance and dysphagia symptom assessment after treatment for achalasia. United European Gastroenterology Journal 2015:1-7.
Jun 1, 2015Correlation of esophageal clearance and dysphagia symptom assessment after treatment for achalasia
Jun 1, 2015United European Gastroenterology Journal 2015:1-7
Krieger-Grübel Claudia, Tutuian Radu, Borovicka Jan
The contribution of intrabolus pressure to symptoms induced by gastric banding
Preissler C, Krieger-Grübel C, Borovicka J, Fried M, Tutuian R. The contribution of intrabolus pressure to symptoms induced by gastric banding. J Gastrointestin Liver Dis 2014; 23:13-7.
Mar 1, 2014The contribution of intrabolus pressure to symptoms induced by gastric banding
Mar 1, 2014J Gastrointestin Liver Dis 2014; 23:13-7
Preissler Claudia, Krieger-Grübel Claudia, Borovicka Jan, Fried Michael, Tutuian Radu
Physiology of diffuse esophageal spasm (DES)--when normal swallows are not normal
Krieger-Grübel C, Hiscock R, Nandurkar S, Heddle R, Hebbard G. Physiology of diffuse esophageal spasm (DES)--when normal swallows are not normal. Neurogastroenterol Motil 2010; 22:1056-e279.
Jun 21, 2010Physiology of diffuse esophageal spasm (DES)--when normal swallows are not normal
Jun 21, 2010Neurogastroenterol Motil 2010; 22:1056-e279
Krieger-Grübel Claudia, Hiscock R, Nandurkar S, Heddle R, Hebbard G